BIOMAT Database Logo BIOMAT Database Logo

Effect of mannitol on acute amphotericin B nephrotoxicity. 1980

R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin

This study was undertaken to examine the value of mannitol as protection against the acute nephrotoxicity of amphotericin B under controlled conditions in a reproducible model of toxicity in the dog. Eleven dogs received amphotericin B, 2.5 mg x kg-1 b. wt. by i.v. infusion over a 4-h period. Six dogs were treated with mannitol, 6.25 g, i.v. every hour and five served as controls. Urinary volume (V), inulin clearance (CIn), p-aminohippurate clearance (CPAH), and Na excretion (UNaV) were measured every hour throughout the experiment. Although a higher urinary output was maintained in mannitol-treated dogs, a progressive decline in renal function was observed in treated and in control dogs. During the 4th h, mannitol-treated dogs showed higher CIn (37.4 vs. 19.7 ml x min-1 and CPAH (95 vs. 54 ml x min-1 than controls. However, statistically the differences were barely significant. The results fail to show that mannitol offers a definite protection against amphotericin B nephrotoxicity.

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Mitigation of amphotericin B nephrotoxicity by mannitol.
March 1975, British medical journal,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Reduction of amphotericin B nephrotoxicity with mannitol.
May 1976, JAMA,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Use of mannitol to prevent amphotericin B nephrotoxicity.
May 1987, Clinical pharmacy,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Effect of an adenosine receptor antagonist on acute amphotericin B nephrotoxicity.
March 1990, European journal of pharmacology,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
The value of mannitol in reducing the nephrotoxicity of amphotericin B.
January 1971, Surgical forum,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
The use of mannitol to reduce the nephrotoxicity of amphotericin B.
February 1972, Surgery, gynecology & obstetrics,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Effect of salt supplementation on amphotericin B nephrotoxicity.
August 1991, Kidney international,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Amphotericin B nephrotoxicity.
August 1988, American family physician,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Amphotericin B nephrotoxicity.
January 1990, Drug safety,
R Said, and P Marin, and H Anicama, and A Quintanilla, and M L Levin
Amphotericin B nephrotoxicity.
January 2002, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,
Copied contents to your clipboard!